WHO backs wider use of weight-loss medicines, calling obesity a chronic disease

WHO backs wider use of weight-loss medicines, calling obesity a chronic disease

The guidance focuses on GLP-1 therapies – medicines such as liraglutide, semaglutide and tirzepatide – and…

Continue Reading
WHO adds weight-loss, diabetes drugs to essential medicines list | World Health Organization News

WHO adds weight-loss, diabetes drugs to essential medicines list | World Health Organization News

UN agency urges production of affordable generics for GLP-1 drugs to treat obesity and diabetes in…

Continue Reading
Geriatric Medicines Market Growing Elderly Population and

Geriatric Medicines Market Growing Elderly Population and

Burlingame, CA, June 18, 2025 (GLOBE NEWSWIRE) — The global Geriatric Medicines Market is estimated to be…

Continue Reading
Geriatric Medicines Market Revenue to Attain USD 324.09 Bn by 2033

Geriatric Medicines Market Revenue to Attain USD 324.09 Bn by 2033

Table of Content Geriatric Medicines Market Revenue and Trends 2025 to 2033 The global geriatric medicines…

Continue Reading
Geriatric Medicines Business Research Report 2024-2030:

Geriatric Medicines Business Research Report 2024-2030:

Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) — The “Geriatric Medicines – Global Strategic Business Report” report…

Continue Reading
WHO issues warning on falsified medicines used for diabetes treatment and weight loss

WHO issues warning on falsified medicines used for diabetes treatment and weight loss

The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of…

Continue Reading